Betta Pharmaceuticals Co. Ltd. logo

Betta Pharmaceuticals Co. Ltd. (300558)

Market Open
11 Jun, 06:57
XSHE XSHE
¥
51. 80
+1.19
+2.3513%
¥
20.32B Market Cap
- P/E Ratio
0.8% Div Yield
4.09M Volume
- Eps
¥ 50.61
Previous Close
Add Transaction
Day Range
50.03 52.07
Year Range
40.1 79.8
Want to track 300558 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Betta Pharmaceuticals Co. Ltd. (300558) Statistics

Valuation metrics

Market Cap 20.32B
Enterprise value 22.71B
Trailing P/E (ttm) 46.68
Forward P/E -
PEG ratio 5.66
Price/Sales (ttm) 5.51
Price/Book (mrq) 3.03
Enterprise Value/Revenue 6.08
Enterprise Value/EBITDA 29.44

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 14.98M
Average volume (90 days) 10.37M

Price summary

52-Week low 40.1
52-Week high 79.8
Beta -
50-Day moving average 49.3
200-Day moving average 47.29

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.2
Trailing annual dividend yield 0.0041%
5-Year annual dividend yield -
Payout ratio 0.3
Dividend Date 9 Jun 2026
Ex-Dividend Date 9 Jun 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.12%
Operating margin 0.15%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.07%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 8.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.05
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.21
Total debt (mrq) -
Total Debt/Equity (mrq) 0.38
Current ratio (mrq) 0.99%
Book value per share (mrq) 16.29

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -